Key Insights

Highlights

Success Rate

69% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

11.4%

4 terminated out of 35 trials

Success Rate

69.2%

-17.3% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

33%

3 of 9 completed with results

Key Signals

3 with results69% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (11)
Early P 1 (1)
P 1 (5)
P 2 (5)
P 3 (1)

Trial Status

Unknown9
Completed9
Withdrawn5
Recruiting5
Terminated4
Active Not Recruiting2

Trial Success Rate

69.2%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (35)

Showing 20 of 20 trials
NCT03650894Phase 2Active Not Recruiting

Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients

NCT04075305Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

NCT06251544Phase 1Not Yet Recruiting

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

NCT04852926Completed

Study of the Sexual Health of Patients Treated for Breast Cancer and Followed up in the Observatory of Fertility at Jeanne de Flandre Hospital.

NCT04692818Not ApplicableRecruitingPrimary

3D Ultrasound Breast Imaging

NCT05252390Phase 1Terminated

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

NCT05169437Phase 2Terminated

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

NCT01827969Not ApplicableWithdrawnPrimary

Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy

NCT01766297Phase 2Recruiting

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

NCT01758445Phase 2Active Not Recruiting

Proton Radiation for Stage II/III Breast Cancer

NCT06597175Phase 3Completed

Evaluating Investigational Medical Device for Breast Tumor Diagnosis Using Diffusion Optical Spectroscopy

NCT03870620Recruiting

Metastatic Breast Cancer in Austria

NCT06172270CompletedPrimary

Sub-regional Tumor Segmentation Based on CEUS Perfusion Characteristics: Enhancing Breast Tumor Diagnosis

NCT06471673Phase 1Recruiting

A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer

NCT04541225Phase 1Terminated

Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors

NCT05191004Phase 1Withdrawn

Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC

NCT04805775Not ApplicableCompleted

Desflurane and Postoperative Sleep Quality in Patients Undergoing Elective Breast Surgery

NCT05544123Unknown

The Treatment Situation of Chinese County Population With Breast Cancer

NCT02725658Not ApplicableWithdrawnPrimary

Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using DOSI

NCT02340468WithdrawnPrimary

Breast Tumor Oxygenation During Exercise

Scroll to load more

Research Network

Activity Timeline